Impact of Rivastigmine on Cognitive Dysfunction and Falling in Parkinson's Disease Patients

Abstract

This study suggests that the degree of cognitive impairment is closely associated with the incidence of falls, and the cholinesterase inhibitor Rivastigmine can delay the deterioration of cognitive function and lower the incidence of falls in PD patients.